Sign Up Today and Learn More About Cyrano Therapeutics Stock
Invest in or calculate the value of your shares in Cyrano Therapeutics or other pre-IPO companies through EquityZen's platform.
Cyrano Therapeutics Stock (CYAT)
Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.
About Cyrano Therapeutics Stock
Founded
2014
Headquarters
Washington, DC, US
Industries
Software, Artificial Intelligence, Data and Analytics
Cyrano Therapeutics Press Mentions
Stay in the know about the latest news on Cyrano Therapeutics
Nasal Spray for Phosphodiesterase Inhibitors
patents • Apr 02, 2025
Gel Treatment for Loss of Taste and Smell
patents • Apr 02, 2025
Implants for Loss of Taste and Smell
patents • Apr 02, 2025
Treatment for taste and smell loss
patents • Apr 02, 2025
Cyrano Therapeutics’ Option Agreement with KYORIN
globallegalchronicle • Mar 06, 2025
Cyrano Therapeutics Management
Leadership team at Cyrano Therapeutics
Board Member
Taka Koda
Founder
Robert Henkin
Join now and verify your accreditation status to gain access to:
- Cyrano Therapeutics Current Valuation
- Cyrano Therapeutics Stock Price
- Cyrano Therapeutics Management
- Available deals in Cyrano Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Cyrano Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Cyrano Therapeutics Revenue and Financials
- Cyrano Therapeutics Highlights
- Cyrano Therapeutics Business Model
- Cyrano Therapeutics Risk Factors
- Cyrano Therapeutics Research Report from SACRA Research
Trading Cyrano Therapeutics Stock
How to invest in Cyrano Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Cyrano Therapeutics through EquityZen funds. These investments are made available by existing Cyrano Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cyrano Therapeutics stock?
Shareholders can sell their Cyrano Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
